Contact Us | (336) 375-2991
Join Our Mailing List
AxxiTrials.com
Axxcelerate Your Trials

AxxiTRIALS Portal and CoSign Digital Signatures Enable Accelerated Site and Study Initiations6/16/2014

Litera, vanguard in risk and productivity management solutions, and ARX Inc., the global leader in digital signature solutions, are pleased to announce that the Litera AxxiTRIALS clinical trial site portal is now powered by version 6 of the CoSign digital signature system. The new features in this latest release of ARX further the AxxiTRIALS powerful and 21 CFR Part 11 compliant Esignature functionality.

Litera AxxiTRIALS, a secure portal solution that speeds trial operations processes from Feasibility to Close-Out, helps complete studies on time, on budget and with the quality of data required. In the AxxiTRIALS portal, trial teams (including sponsors, CROs, investigators and IRBs) work together on clinical trials collaborating on documents while avoiding the delays and costs typically associated with paper-based studies.

The CoSign digital signature engine enables AxxiTRIALS to completely eliminate the need to reintroduce paper each time a signature is required, and also eliminates courier fees and other paper-related costs. Now, with the latest release from ARX, users can expedite their site and study initiation and continue site activities at lower costs, while gaining significant cost savings considering the range of documents that require signatures and the number of sites that can be involved in a single study.

Susan Lewenz, Vice President and General Manager at Litera AxxiTRIALS, notes: "We are big believers in reducing paper in the trials and CoSign has been a huge part of this. This new release furthers the power under the AxxiTRIALS "hood". Our AxxiTRIALS clients are now able to collect 85% of the signatures they need in a period of 24-48 hours."

"CoSign is a key tool for Pharma companies seeking to accelerate processes," says Rodd Schlerf, FDA Markets Manager at ARX. "AxxiTRIALS is a great example of how collaborative cloud services can also benefit from integrating CoSign into their systems in order to provide their users with the ability to securely and compliantly sign documents."

About Litera

Litera offers a comprehensive content risk management suite of cyber-secure document creation, collaboration, and control technology that provides organizations with unsurpassed Content Confidence®. Litera's patented solutions increase productivity throughout the document lifecycle, and enable more secure and effective collaboration between people, teams and organizations to empower ideas that drive success. Litera solutions offer information workers and mobile professionals the ability to manage their documents and data with a degree of control not available through any other applications on the market. Learn more at www.litera.com.

About CoSign by ARX

CoSign by ARX is the most widely used digital signature solution in the life sciences market, employed by over 20,000 FDA-regulated organizations including 9 of the top 10 Pharmas and 7 of the top 10 CROs. It is the only digital signature system that supports compliance with strict industry requirements including the FDA's 21 CFR part 11 and GxP audits. CoSign was recognized as "the strongest digital signature solution" in the Forrester Wave: E-Signatures 2013 report.

By seamlessly integrating digital signatures into their workflows, applications and services, our life sciences customers transformed their slow and expensive signature-dependent processes into quick and efficient paper-free ones. They rapidly reach ROI through reductions in process times and paper-related costs, while ensuring trust, integrity, control and compliance across their business and IT environments.

Visit our web site to learn more about how your Life Sciences organization can benefit from the CoSign digital signature solution.

###

CoSign is a registered trademark of Algorithmic Research, Ltd. Litera® is a registered trademark of Litera Corp. All other trade names and trademarks are the property of their respective holders.

Press release orginally published by CoSign by Arx, Inc.

Upcoming Events:

DIA 2016 52nd Annual Meeting

Philadelphia, PA
June 26-30, 2016

Past Events:

DIA 2015 51st Annual Meeting

Walter E. Washington Convention Center
Washington, DC
June 14-18, 2015

Partnerships in Drug Delivery

Intercontinental Boston
Boston, MA
October 5-6, 2015

Q1 Pharmaceutical & Device Legal & Compliance Forum

Sheraton Pentagon City
Arlington, VA 22204
March 24-25, 2014

CLINICAL STUDY TEAMWORK

iiBIG Clinical Study Teamwork: Building Effective Partnerships
Embassy Suites
Raleigh-Durham/RTP, NC
April 10-11 2014